MedTrace Logo

Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis

NCT05838144 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-07-18

No results posted yet for this study

Summary

1. Acapella group. Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program .
2. Only routine physical therapy program group ( control group). Will only take medications and routine chest physical therapy program.

Conditions

Interventions

DEVICE

Acapella device

Group A. Will use Acapella device.

OTHER

Only routine chest physical therapy program

Group B. Will take medications and perform routine chest physical therapy program.

Sponsors & Collaborators

  • South Valley University

    lead OTHER

Principal Investigators

  • Shymaa Y Abo zaid · Lecturer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2023-09-30
Completion
2023-10-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05838144 on ClinicalTrials.gov